A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy - Rubinstein, Tammi Arbel (Institute of Oncology, Tel Aviv Sourasky Medical Center) ; Reuveni, Inbal (Institute of Oncology, Tel Aviv Sourasky Medical Center) ; Hesin, Arkadi (Institute of Oncology, Tel Aviv Sourasky Medical Center) ; Klein-Goldberg, Anat (Institute of Oncology, Tel Aviv Sourasky Medical Center) ; Olauson, Hannes (Karolinska Institutet (Estocolm, Suècia)) ; Larsson, Tobias E. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Abraham, Carmela R. (Boston University School of Medicine. Department of Biochemistry) ; Zeldich, Ella (Boston University School of Medicine. Department of Biochemistry) ; Bosch i Merino, Assumpció (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Chillón Rodríguez, Miguel (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Hollander, Kenneth Samuel (Institute of Oncology, Tel Aviv Sourasky Medical Center) ; Shabtay-Orbach, Ayelet (Institute of Oncology, Tel Aviv Sourasky Medical Center) ; Vainer, Gilad W. (Pathology Institute, Tel Aviv Sourasky Medical Center) ; Wolf, Ido (Institute of Oncology, Tel Aviv Sourasky Medical Center) ; Rubinek, Tami (Institute of Oncology, Tel Aviv Sourasky Medical Center)
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.